Dr. Kathleen S. Wilson is the Director of the Cytogenomic Microarray Analysis (CMA) laboratory in the Genetic Diagnostics Laboratories. She established the first CMA Laboratory for patient diagnostics in North Texas in 2008, bringing this technologically advanced form of high resolution chromosome analysis for clinical care to U.T. Southwestern and the North Texas region. She completed her undergraduate education at Amherst College and graduated with honors in 1986. She received her medical degree in 1991 from The University of Texas Southwestern Medical Center at Dallas. She subsequently completed pathology residency and genetics fellowship training also at UT Southwestern. 

Dr. Wilson is a faculty member in the Department of Pathology and the McDermott (Genetics) Center for Human Growth and Development. She is board-certied by the American Board of Pathology (ABP) in Clinical Pathology and the American Board of Medical Genetics (ABMG) in Clinical Cytogenetics. She is also a fellow of the College of American Pathologists (CAP) and the American College of Medical Genetics (ACMG). 

She has served on the Cytogenetics Resource Committee (CyRC) of the CAP and ACMG for over a decade and was involved in setting national policy for cytogenetics and molecular cytogenomics by developing accreditation guidelines and issuing proficiency testing. She has served as chair of the Economics of Genetic Services Committee for ACMG and has also been an active participant nationally in policy related to reimbursement for high complexity genetic testing.  She is currently involved in multiple medical school administrative and educational activities in her roles as Chair of the UT Southwestern Medical School Admissions Committee and Co-Director of the Medical Student Genetics Course.

Dr. Wilson’s interest and experience in molecular genetics and genomics have been longstanding with recent publications in The Journal of Pediatric Hematology Oncology and Pediatric and Developmental Pathology, and book chapters in Abeloff: Clinical Oncology, 4th ed., Clinical Laboratory Hematology, 3rd ed. and Rosenberg’s Molecular and Genetic Basis of Neurological and Psychiatric Disease, 5th ed. 

Dr. Wilson has won teaching awards and has been actively involved in the teaching and mentorship of medical and graduate students, house staff, and junior faculty for over twenty-five years.


Medical School
UT Southwestern Medical School (1991)
UT Southwestern Medical Center (1992), Pathology
UT Southwestern Medical Center (1994), Pathology
UT Southwestern Medical Center (1995), Hematopathology
UT Southwestern Medical Center (1997), Cytogenetics

Research Interest

  • My research interests are focused on the clinical utilization of multiple genetic diagnostic technologies (next generation sequencing, cytogenomic microarray analysis, fluorescence in situ hybridization and conventional cytogenetics) in an integrated approach to elucidate the pathogenetic events of both constitutional and acquired (neoplastic) disorders.


Featured Publications LegendFeatured Publications

Cytogenetic and Cytogenomic Microarray Characterization of Chromothripsis in Chromosome 8 Affecting MOZ/NCOA2 (TIF2), FGFR1, RUNX1T1, and RUNX1 in a Pediatric Acute Myeloid Leukemia.
Koduru PR, Wilson K, Wen J, Garcia R, Patel S, Monaghan SA J. Pediatr. Hematol. Oncol. 2017 Jan
JAK-STAT6 Pathway Inhibitors Block Eotaxin-3 Secretion by Epithelial Cells and Fibroblasts from Esophageal Eosinophilia Patients: Promising Agents to Improve Inflammation and Prevent Fibrosis in EoE.
Cheng E, Zhang X, Wilson KS, Wang DH, Park JY, Huo X, Yu C, Zhang Q, Spechler SJ, Souza RF PLoS ONE 2016 11 6 e0157376
Novel r(2)(p25q31) Cytogenetic Abnormality in a Pediatric Patient With Acute Leukemia of Ambiguous Lineage.
Kim J, Bu L, Koduru PR, Wilson KS, Fuda FS, Kumar KR, Timmons CF, Slone TL, Luu HS Pediatr. Dev. Pathol. 2014 Dec
Therapy-induced Secondary Acute Myeloid Leukemia With t(11;19)(q23;p13.1) in a Pediatric Patient With Relapsed Acute Promyelocytic Leukemia.
Dang DN, Morris HD, Feusner JH, Koduru P, Wilson K, Timmons CF, Cavalier M, Luu HS J. Pediatr. Hematol. Oncol. 2014 Jun
Response to Mariani Et al.: A second report of PARK2 duplication and developmental delay.
Scheuerle AE, Wilson KS Am. J. Med. Genet. B Neuropsychiatr. Genet. 2013 Jul 162 5 484
The clinical consequences of hemizygosity across 2 MB of 10q23 are restricted to Cowden syndrome.
Lewis CM, Bu D, Sarode V, Robinson L, Wilson KS, Viscusi RK, Eng C, Euhus DM Breast Cancer Res. Treat. 2012 Dec 136 3 911-8
High-resolution array CGH identifies common mechanisms that drive embryonal rhabdomyosarcoma pathogenesis.
Paulson V, Chandler G, Rakheja D, Galindo RL, Wilson K, Amatruda JF, Cameron S Genes Chromosomes Cancer 2011 Jun 50 6 397-408

Honors & Awards

  • Doximity Recognition
    Top M.D. by Consumers Checkbook (2017)
  • Outstanding Teacher in Genetics: Pre-Clinical Teaching Award
    UT Southwestern Class of 2015 (2012)
  • Guide to America's Top Pathologists
    Consumers' Research Council of America (2007-present) (2007)
  • Outstanding Teacher in Pathology
    UT Southwestern Class of 2009 (2007)
  • Small Group Teaching Award in Pathology
    UT Southwestern Class of 2009 (2007)
  • Favorite Teacher Recognition in Pathology
    UT Southwestern Class of 2007 (2005)
  • Guide to America's Top Physicians
    Consumers' Research Council of America (2004-present) (2004)
  • Amherst College: Graduation with Honors
    B.A., magna cum laude (1986)
  • Aston L. Clarke Research Fellowship
    UT Southwestern Medical Center at Dallas (1985)

Professional Associations/Affiliations

  • American College of Medical Genetics (2002)
  • American Medical Association (1991)
  • College of American Pathologists (1993)
  • Dallas County Medical Society (1991)
  • Texas Medical Association (1991)